Trademark: 88832104
Word
ELISPHYRE
Status
Pending
Status Code
734
Status Date
Wednesday, February 28, 2024
Serial Number
88832104
Mark Type
4000
Filing Date
Thursday, March 12, 2020
Published for Opposition
Tuesday, July 6, 2021

Trademark Owner History
Ascendis Pharma Bone Diseases A-S - Owner At Publication

Classifications
9 Downloadable computer software and downloadable computer programs for use in providing medical advice and advice on medications for treatment, patient assistance and health insurance in the field of hypoparathyroidism, growth disorders, endocrine disorders and bone disorders; downloadable computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely, a downloadable software application for sharing information related to hypoparathyroidism, growth disorders, endocrine disorders and bone disorders and the treatment of hypoparathyroidism, growth disorders, endocrine disorders, bone disorders for use by patients with growth hormone disorders, hypoparathyroidism and skeletal dysplasia in the medical field of hypoparathyroidism, growth disorders, endocrine disorders and bone disorders; downloadable computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely, downloadable software that coordinates the delivery of health care services between health care providers, patients and those parties responsible for the payment of health care services, namely, downloadable software that allows individuals seeking medical education, information and services to locate a physician and treatment facility in their geographic area for medical treatment and allows physicians and health care professionals to communicate their credentials and specialization to patients and parties responsible for payment of healthcare services; downloadable computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely, downloadable software that enables health care providers to monitor patients, communicate clinical information relevant to a patient's care, provide and exchange information concerning patients and the health care services provided to patients; downloadable software, downloadable software applications and downloadable mobile applications for providing co-pay and other financial or medical access support; downloadable computer software for providing a communications platform enabling users to share health and healthcare information; downloadable software, downloadable software applications and downloadable mobile applications for the measurement of height, weight, blood pressure, serum calcium, blood glucose, and heart rate; downloadable software, downloadable software applications and downloadable mobile applications for providing, exchanging, retrieving and analyzing health and healthcare information; downloadable software for medical purposes, namely, for formatting, viewing and transmitting medical data collected and stored on hormone injection pens and pumps and between said injection pens and pumps and portable electronic devices; downloadable computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely, a downloadable software application for providing healthcare-related information, medication reminders, and tracking medication dosing history; the foregoing downloadable software related to pharmaceutical preparations for the treatment of hypoparathyroidism, growth disorders, endocrine disorders and bone disorders
5 Pharmaceutical preparations for the treatment of hypoparathyroidism; pharmaceutical preparations for the treatment of growth disorders, pharmaceutical preparations for the treatment of endocrine disorders, pharmaceutical preparations for the treatment of bone disorders; diagnostic preparations for medical use, namely, diagnostic preparations for identifying and detecting hypoparathyroidism, endocrine disorders and bone disorders
10 Medical devices for injection, dosage and control of pharmaceuticals, namely, medical devices for injection, dosage measurement and monitoring of pharmaceuticals for the treatment of hypoparathyroidism, growth disorders, endocrine disorders and bone disorders; syringes for medical purposes and for injections; syringes for injection for medical and surgical use, namely, syringes in the form of pens for surgical use; digitally connected medical devices for monitoring the dispensation of pharmaceutical preparations for use in connection with management of growth hormone disorders, hypoparathyroidism and skeletal dysplasia; medical apparatus, namely, infusion and injection devices for administering drugs; medical apparatus for diagnostic purposes, namely, medicine dosage dispensers containing software featuring web-based medical information for physical and psychological examination and assessment of patients remotely and at a clinic; dosage management dispensers containing software for medical information management for guidance and control of medicines and for therapeutic use in web-based physical and psychological examination and assessment of patients remotely and at a clinic

Trademark Events
Feb 29, 2024
Notice Of Approval Of Extension Request E-Mailed
Feb 28, 2024
Sou Extension 5 Granted
Feb 28, 2024
Sou Extension 5 Filed
Feb 28, 2024
Sou Teas Extension Received
Sep 1, 2023
Notice Of Approval Of Extension Request E-Mailed
Aug 30, 2023
Sou Extension 4 Granted
Aug 30, 2023
Sou Extension 4 Filed
Aug 30, 2023
Sou Teas Extension Received
Feb 24, 2023
Notice Of Approval Of Extension Request E-Mailed
Feb 22, 2023
Sou Extension 3 Granted
Feb 22, 2023
Sou Extension 3 Filed
Feb 22, 2023
Sou Teas Extension Received
Aug 25, 2022
Notice Of Approval Of Extension Request E-Mailed
Aug 23, 2022
Sou Extension 2 Granted
Aug 23, 2022
Sou Extension 2 Filed
Aug 23, 2022
Sou Teas Extension Received
Jan 26, 2022
Notice Of Approval Of Extension Request E-Mailed
Jan 24, 2022
Sou Extension 1 Granted
Jan 24, 2022
Sou Extension 1 Filed
Jan 24, 2022
Sou Teas Extension Received
Aug 31, 2021
Noa E-Mailed - Sou Required From Applicant
Jul 6, 2021
Official Gazette Publication Confirmation E-Mailed
Jul 6, 2021
Published For Opposition
Jun 16, 2021
Notification Of Notice Of Publication E-Mailed
Jun 1, 2021
Approved For Pub - Principal Register
Jun 1, 2021
Teas/Email Correspondence Entered
Jun 1, 2021
Correspondence Received In Law Office
May 26, 2021
Teas Response To Suspension Inquiry Received
May 3, 2021
Notification Of Letter Of Suspension E-Mailed
May 3, 2021
Letter Of Suspension E-Mailed
May 3, 2021
Suspension Letter Written
Mar 15, 2021
Teas/Email Correspondence Entered
Mar 15, 2021
Correspondence Received In Law Office
Mar 11, 2021
Assigned To Lie
Dec 9, 2020
Teas Response To Office Action Received
Jun 9, 2020
Notification Of Non-Final Action E-Mailed
Jun 9, 2020
Non-Final Action E-Mailed
Jun 9, 2020
Non-Final Action Written
Jun 4, 2020
Assigned To Examiner
Mar 18, 2020
New Application Office Supplied Data Entered
Mar 16, 2020
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24